Demand In Feminine Care And Incontinence Will Expand Internationally

Published
07 Nov 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
SEK 288.75
11.6% undervalued intrinsic discount
20 Aug
SEK 255.30
Loading
1Y
-15.1%
7D
3.1%

Author's Valuation

SEK 288.8

11.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 9.65%

Shared on23 Apr 25
Fair value Increased 1.31%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 0.12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.31%

AnalystConsensusTarget has decreased revenue growth from 2.5% to 2.1%.

Shared on02 Apr 25
Fair value Increased 0.74%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.75%

AnalystConsensusTarget has decreased revenue growth from 3.4% to 2.7%.

Shared on19 Mar 25
Fair value Decreased 3.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 5.30%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.